Karan is the chief operating officer of Headspace Health, where he leads the company’s clinical operations and strategy. He was previously COO of Ginger. He has over 13 years of experience in the healthcare industry, consulting with bio-pharma clients, commercializing data analytics and establishing research partnerships with academic medical centers. A leader in the digital health community, Karan is a frequent speaker about entrepreneurship, health innovation and new models of care. He has served as a scholar at the Aspen Institute, delivered keynotes at the Public Health Institute and the National Institute of Mental Health and was recognized as a rising star in healthcare by LinkedIn's Next Wave.About Tales from the Trenches™MATTER’s signature Tales from the Trenches series is an opportunity to hear the early stories of some of the global businesses we read about in the news — straight from the founders who led them to greatness. This series invites seasoned healthcare entrepreneurs to the MATTER stage to share learnings, stories and key takeaways from their journeys.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

In this era of mergers and collaborations, Walgreens invested $5.2 billion in VillageMD to open hundreds of Village Medical at Walgreens practices across the country. Village Medical locations are spacious, featuring experienced primary care doctors and their clinical teams. The physician-led model allows for high-quality, accessible healthcare right in the communities — and health equity is an incredibly important topic that both companies believe passionately in.MATTER and Mark Vainisi, senior vice president of corporate development and strategy at VillageMD, and Anita Allemand, chief transformation and integration officer of Walgreens Boots Alliance, discuss how the two organizations came to collaborate on Village Medical and what the next generation of healthcare looks like.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

What will healthcare look like in 20 years? What should we invest in today to help us get there?MATTER and Baxter present Healthcare 2040, an event series that invites industry leaders working in significantly transformative areas of healthcare to help us explore these questions.Leading up to National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, join us for a critical discussion on the future of chronic pulmonary care. Chronic pulmonary conditions include COPD, pulmonary fibrosis, asthma and more. The prevalence of these conditions is increasing — for instance, in 2019, COPD was the third leading cause of death worldwide, causing 3.23 million deaths. In recent years, chronic pulmonary conditions have been further compounded by the onset of the COVID-19 pandemic and intensifying climate change.COPD Foundation President and CEO Dr. Ruth Tal-Singer, Baxter Chief Scientist of Respiratory Health Division Tom Westfall and St. Lawrence Health System Pulmonologist and Medical Director of Population Health Dr. Frederic Seifer joined moderator and Baxter Vice President of Medical Affairs Carlos Urrea to discuss the current state of chronic pulmonary conditions and how innovation can shape its future.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

MATTER recently launched 51 Labs, a women+’s health accelerator. With sponsors and partners Astellas Pharma US, Walgreens, BayCare, Parkview Health and University of Chicago Medicine, the inaugural year’s program calls for innovative healthcare solutions that empower and support women+ during their menopausal transition.On October 19, University of Chicago Medicine (UCM) Center for Women’s Integrated Health Director and practicing UCM physician Dr. Monica Christmas and Walgreens Boots Alliance Director of Consumer Healthcare Futures Marni Allen joined us for a panel discussion on the need for innovation in women+’s health and menopause and the disparities across the menopausal experience and care among underrepresented women.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

Dr. Iman Abuzeid is a healthcare workforce extraordinaire. As CEO and co-founder of Incredible Health, the fastest-growing career marketplace for permanent healthcare workers, she helps healthcare professionals live better lives and find and do their best work.Prior to Incredible Health, Iman founded Lift League, a platform for mobile and web applications that made it easy for wellness professionals to improve client results, build relationships and increase retention.Iman is also an NFX member and scout at Sequoia Capital, making her a well-rounded expert in both the venture capital and healthcare management consulting verticals.On August 25, Iman joined MATTER and Danielle Smith, chief nursing officer of VillageMD, to discuss startup scalability, healthcare technology and what’s next for Incredible Health.This Tales from the Trenches™ is produced in partnership with VillageMD.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

What will healthcare for older adults look like in 20 years? What innovations should we invest in today to help us get there?MATTER and Baxter present Healthcare 2040, an event series that invites industry leaders working in significantly transformative areas of healthcare to help us explore these questions.How are we conceptualizing what it is to age? How is technology truly supporting all of us as we age? What will care outside of the hospital look like in 2040, and what will the gaps be?Stanford Health Care Associate Chief Nursing Informatics Officer Gretchen Brown and RRF Foundation for Aging President Mary O’Donnell discussed these questions and more in a conversation moderated by Baxter Vice President of Medical Affairs Carlos Urrea.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

According to the American Academy of Dermatology, skin cancer is the most common form of cancer, with one in every five Americans estimated to develop it in their lifetime. With the prevalence of skin cancer continuing to increase among adults and children, advancements in technology may be the key to prevention.Traci Dunn, chief human resources officer and head of diversity, equity and inclusion at VillageMD, lead us through a conversation with Scott Barrows, director of the OSF Innovation Design Lab, Kyoko Crawford, co-founder and CEO of SkinIO and Sam Glassenberg, founder and CEO of Level Ex, where they will explore the burden of skin cancer across various communities, the importance of early detection and screening for prevention and how the development of inclusive and accessible technologies are key to assisting providers and health systems with supporting patients.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

Paris Wallace is an enterprise expert who has founded two successful companies in the women+’s and reproductive health space. As co-founder of Ovia Health, the leading women+’s health and technology company focusing on fertility, pregnancy and parenting programs, Paris has helped empower women and families to take control of their healthcare. ​​As a recognized leader in the space, Ovia Health was acquired by Labcorp in 2021.Prior to Ovia Health, Paris founded Good Start Genetics, a genomics technology company focused on fertility and reproductive health. His first effort in the health tech space made waves, resulting in Good Start Genetics’ acquisition by Invitae in 2017.With a highly successful career thus far, Paris is not done yet. He is currently an entrepreneur in residence at Harvard Business School and is working on various diversity, equity and inclusion (DEI) and gender equality projects, providing a unique and impactful lens to entrepreneurship.On July 20, Paris joined MATTER and Dr. Sheila Bhagavan from VillageMD to discuss his career, Ovia Health’s acquisition by Labcorp and what’s next in his journey.This Tales from the Trenches™ is produced in partnership with VillageMD. For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

What will healthcare look like in 20 years? What innovations should we invest in today to help us get there?MATTER and Baxter present Healthcare 2040, an event series that invites industry leaders working in significantly transformative areas of healthcare to help us explore these questions. Our next event in this forward-looking series will ask: How will we address current personnel burnout? How has the pandemic affected the healthcare workforce, and what solutions are going to solve our current staffing challenges? What will staffing look like in 2040, and what will the gaps be? Legacy Community Health Chief Information Officer David Chou and UNC REX Healthcare Vice President of Patient Care Services and Chief Nursing Officer Joel Ray discussed these questions and more in a conversation moderated by Baxter Vice President Medical Affairs Carlos Urrea.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

Dr. Chad Mirkin is a world-renowned chemist who has taken an entrepreneurial approach to his nanotechnology research. He is the director of the International Institute for Nanotechnology and the George B. Rathmann professor of chemistry. He is also a professor of chemical and biological engineering, biomedical engineering, materials science and engineering and medicine at Northwestern University. Dr. Mirkin is known for the invention of the spherical nucleic acid and its development in biodetection and therapeutic schemes, which was named by National Geographic as one of the top 100 scientific discoveries that changed the world, among other innovations. He has published over 830 manuscripts and has over 1,200 patents and patent applications, which lends him a unique perspective on healthcare product development. In addition to his academic and research work, Dr. Mirkin has been involved in shaping scientific policy. In 2009, he was appointed to President Barack Obama's President's Council of Advisors on Science and Technology and served until 2017, allowing his expertise to be impactful globally. On June 21, Dr. Mirkin joined MATTER and Jeff Aronin from Paragon Biosciences to discuss his dynamic career, lessons in nanotechnology and what’s next for his research at Northwestern. This Tales from the Trenches™ is produced in partnership with Paragon Biosciences.For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth